Can lung cancer be cured by taking Osimertinib?

Lung cancer is the deadliest form of cancer and often shows no symptoms in its early stages, meaning diagnosis can easily be missed. In turn, treatment may become more challenging when a diagnosis is finally diagnosed. Even if lung cancer patients have their tumors removed or receive chemotherapy, the five-year survival rate is currently only about 25%. The drug Osimertinib, taken once daily, can reduce the risk of death in lung cancer patients by 51%.

Osimertinibbelongs to a group of drugs called"kinase inhibitors." These drugs block the action of abnormal proteins that signal cancer cells to multiply and slow their spread. The trial included 682 patients with non-small cell lung cancer (NSCLC), all of whom had undergone cancer surgery and were randomly assigned to take either a daily placebo pill or an 80-mg dose of osimertinib, a targeted therapy designed to treat tumors with mutations in the EGFR gene. New research suggests that taking osimertinib after surgery for some patients with early-stage lung cancer may significantly improve their chances of survival.

OsimertinibThe original drug has been launched in China and has entered the scope of medical insurance. Its name is Osimertinib Mesylate Tablets. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. SpecificationThe price of 80mg*30 tablets per box is around RMB 5,000, which is relatively expensive. The original drug of Osimertinib has also been launched overseas, and there are also generics of Osimertinib produced in other countries. For example, the price of 80mg*30 tablets per box produced by Bangladesh Yaopin International is around RMB 850 (the price may fluctuate due to the exchange rate). The price is relatively cheap. The ingredients of the generic Osimertinib and the original drug are basically the same.